2026 In HealthTech M&A, AI Governance Is Now a Line Item on the Term Sheet Buyers in HealthTech and MedTech deals are pricing AI governance maturity directly into valuation, not treating it as a closing condition.
2026 In Physical AI Deals, Telemetry Rights Are the Real Asset Energy and industrial AI transactions increasingly hinge on whether sensor and telemetry data remain usable after closing, not on the model itself.
